Table 1 Clinical characteristics of the study cohort
Demographics | Total (62) | No left ventricular dysfunction (27) | Left ventricular dysfunction (35) | P-value |
|---|---|---|---|---|
Age | 72 (59–76) | 65 (56–75) | 73 (62–76) | 0.119 |
Sex, male n (%) | 30 (48.2) | 13 (48.15) | 17 (48.6) | 0.974 |
SAPS | 64 (56–75) | 59 (52–69) | 66 (58–76) | 0.029 |
SOFA | 9 (7–12) | 9 (5–11) | 10 (8–13) | 0.047 |
Clinical frailty scale | 3 (2–4) | 2 (2–4) | 3 (2–4) | 0.241 |
Coronary artery disease, n (%) | 9 (14.5) | 3 (11.1) | 6 (17.1) | 0.504 |
Heart failure, n (%) | 9 (14.5) | 2 (7.4) | 7 (20.0) | 0.163 |
Diabetes mellitus, n (%) | 10 (16.1) | 4 (14.8) | 6 (17.1) | 0.805 |
Stroke or TIA, n (%) | 10 (16.1) | 3 (11.1) | 7 (20.0) | 0.345 |
Hypertension, n (%) | 43 (69.4) | 15 (55.6) | 28 (80.0) | 0.038 |
S100A8/A9 (µg/mL) | 14.3 (6.9–32.1) | 7.4 (4.5–22.9) | 20.1 (11.8–36.1) | 0.009 |